Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-18 Sale | 2022-01-18 8:34 pm | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 533 | $120.48 | $64,217 | 24,279 (Direct) | View |
| 2022-01-07 Sale | 2022-01-07 8:26 pm | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 345 | $135.94 | $46,900 | 10,525 (Direct) | View |
| 2022-01-04 Sale | 2022-01-06 4:50 pm | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 758 | $147.74 | $111,987 | 10,870 (Direct) | View |
| 2021-01-06 Sale | 2021-01-08 7:57 pm | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 779 | $212.23 | $165,325 | 7,471 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-22 Option Award | 2024-05-24 4:56 pm | N/A 2034-05-21 | Evoke Pharma Inc | EVOK | REED VICKIE S Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-11 4:49 pm | N/A 2033-05-09 | Evoke Pharma Inc | EVOK | REED VICKIE S Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:19 pm | N/A 2029-05-24 | Adamis Pharmaceuticals Corp | ADMP | REED VICKIE S Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-04-27 Option Award | 2022-04-28 7:20 pm | N/A 2032-04-26 | Evoke Pharma Inc | EVOK | REED VICKIE S Director | 58,000 | $0 | 58,000 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-18 8:34 pm | N/A 2032-01-13 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 14,287 | $0 | 24,279 (Direct) | View |
| 2021-05-13 Option Award | 2021-05-17 9:05 pm | N/A 2031-05-12 | Evoke Pharma Inc | EVOK | REED VICKIE S Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 6:18 pm | N/A 2031-01-14 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 10,656 | $0 | 18,127 (Direct) | View |
| 2020-11-02 Option Award(A) | 2020-11-12 6:21 pm | N/A 2030-11-01 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 2,522 | $0 | 2,522 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-06 7:35 pm | N/A 2030-11-01 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 2,523 | $0 | 2,523 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-15 7:38 pm | N/A 2030-01-05 | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 8,250 | $0 | 13,750 (Direct) | View |
Ownership | 2020-01-15 7:36 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer | 0 | $0 | 105,992 (Direct) | View |